MREO — Mereo BioPharma Group plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1719714 ·
United Kingdom
Last close
$0.37
Market Cap
$59.09M
52W High
$2.37
52W Low
$0.20
ADV30
1,599,660
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | 0 | -6,911,000 | -7,005,000 | 34,714,000 | 30,118,000 | 6,062,000 |
| Mar 2026 | 0 | — | -8,671,000 | -6,719,000 | 40,614,000 | 36,223,000 | 6,560,000 |
| Dec 2025 | 0 | 0 | -7,917,000 | -7,351,000 | 45,917,000 | 40,992,000 | 5,001,000 |
| Sep 2025 | 0 | 0 | -9,569,000 | -7,024,000 | 53,602,000 | 48,698,000 | 7,004,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-26,954,000
Investing CF
$0
Financing CF
$-95,000
CapEx
$-620,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.30
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-507,538,000
Inventory
—
Receivables
$1,879,000
ST Investments
—
EBIT TTM
$-35,615,000
Pretax Income TTM
$-35,710,000
Interest Exp TTM
$95,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
$-32,416,000
Free Cash Flow
$-13,656,500
Enterprise Value
$15,625,472
Total Cash
$30,118,000
Total Debt
$1,030,000
Shares Out
159,690,973
Trailing EPS
$-0.20
Book Value
$0.18
ROE
-67.8%
ROA
-42.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 500,000 | -38,257,000 | -41,878,000 | 45,917,000 | 5,001,000 | 40,916,000 | -30,971,000 |
| Dec 2024 | 0 | -45,715,000 | -43,253,000 | 76,390,000 | 15,421,000 | 60,969,000 | -32,834,000 |
| Dec 2023 | 10,000,000 | -27,136,000 | -29,466,000 | 66,499,000 | 15,962,000 | 50,537,000 | -21,132,000 |
| Dec 2022 | 0 | -52,698,000 | -42,220,000 | 77,413,000 | 26,011,000 | 51,402,000 | -48,821,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.02
Max Pain — expiry 2027-01-15
max pain strike: $0.50 · spot: $0.38 · call oi: 7,838 · put oi: 124
Expected Move to 2027-01-15:
±$0.28
(72.27%) —
implied range
$0.11 –
$0.66
· ATM straddle on $0.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PRRUF | IMMUTEP Ltd | $58.95M | $0.04 | — |
| XLO | Xilio Therapeutics, Inc. | $59.48M | $9.04 | — |
| BOLD | Boundless Bio, Inc. | $60.51M | $2.66 | — |
| TLPH | TALPHERA, INC. | $61.25M | $1.18 | — |
| ZYBT | Zhengye Biotechnology Holding Ltd | $61.85M | $1.30 | — |
News headlines (Yahoo Finance, 1h cache)
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
2026-08-11 12:15 · Yahoo
Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
2026-08-11 12:00 · Yahoo
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
2026-08-11 12:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
2026-06-15 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
2026-06-02 15:08 · Yahoo
Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
2026-05-12 11:30 · Yahoo
We're Hopeful That Mereo BioPharma Group (NASDAQ:MREO) Will Use Its Cash Wisely
2026-04-07 13:39 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
2026-04-02 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading
2026-02-24 16:03 · Yahoo
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading
2026-02-11 16:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.